You have 9 free searches left this month | for more free features.

CD47

Showing 26 - 50 of 2,804

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023

Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)

Recruiting
  • Multiple Myeloma
  • TTI-622
  • Daratumumab Hyaluronidase-fihj
  • Basking Ridge, New Jersey
  • +6 more
Dec 8, 2022

Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular

Recruiting
  • Aggressive B-Cell Non-Hodgkin Lymphoma
  • +19 more
  • CD47 Antagonist ALX148
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Advanced Solid Tumor Trial in Kogarah (HX009)

Active, not recruiting
  • Advanced Solid Tumor
  • Kogarah, New South Wales, Australia
    St George Private Hospital
Jul 7, 2021

Solid Tumor Trial in Beijing (SHR2150, Anti-Cancer Agent)

Unknown status
  • Solid Tumor
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Oct 15, 2020

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Erythematotelangiectatic Rosacea Trial in United States (CD07805/47, CD07805/47 )

Completed
  • Erythematotelangiectatic Rosacea
  • Hot Springs, Arkansas
  • +4 more
Feb 16, 2021

Rosacea Trial in United States (CD07805/47 Gel, Vehicle Gel)

Completed
  • Rosacea
  • CD07805/47 Gel
  • Vehicle Gel
  • Hot Springs, Arkansas
  • +19 more
Feb 24, 2021

Hematologic Tumors Trial in Spain, United States (CC-90002, Rituximab)

Completed
  • Hematologic Neoplasms
  • Scottsdale, Arizona
  • +12 more
Aug 10, 2021

Rosacea Trial in Canada, United States (CD07805/47 Gel, Placebo)

Completed
  • Rosacea
  • CD07805/47 Gel
  • Placebo
  • Hot Springs, Arkansas
  • +14 more
Feb 16, 2021

Rosacea Trial in Canada, United States (CD07805/47 gel, Placebo)

Completed
  • Rosacea
  • CD07805/47 gel
  • Placebo
  • Los Angeles, California
  • +14 more
Feb 16, 2021

Rosacea Trial in Canada, United States (Brimonidine 0.33% gel (Br), CD07805/47 (Br) gel, Ivermectin 1% cream (IVM))

Completed
  • Rosacea
  • Brimonidine 0.33% gel (Br)
  • +3 more
  • Fort Smith, Arkansas
  • +12 more
Feb 16, 2021

Rosacea Trial in United States (CD07805/47 gel 0.5%)

Completed
  • Rosacea
  • CD07805/47 gel 0.5%
  • Santa Monica, California
  • +26 more
Feb 16, 2021

Tumors Malignant Trial in Australia (AK117)

Not yet recruiting
  • Neoplasms Malignant
  • Sydney, New South Wales, Australia
  • +4 more
Apr 14, 2020

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New

Recruiting
  • Mantle-cell Lymphoma
  • B Cell Chronic Lymphocytic Leukemia
    • Monza, MB, Italy
      Andrea Aroldi
    May 24, 2023

    Gastric Adenocarcinoma, Pancreas Adenocarcinoma, Gastric Tumor Trial (PT886)

    Not yet recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • (no location specified)
    Aug 10, 2022

    Advanced Tumors Trial (HMPL-A83 injection)

    Not yet recruiting
    • Advanced Tumors
    • HMPL-A83 injection
    • (no location specified)
    Jun 17, 2022

    Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

    Not yet recruiting
    • Small Cell Lung Cancer (SCLC)
    • +3 more
    • (no location specified)
    Dec 7, 2022

    FAPI in Rectal Cancer TNT

    Not yet recruiting
    • Rectal Neoplasms Malignant
    • Ga-68 FAPI
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital
    Nov 27, 2023

    NSCLC, Squamous Cell Carcinoma of the Head and Neck, Ovarian Cancer Trial in United States (PF-07257876)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • PF-07257876
    • Phoenix, Arizona
    • +38 more
    Jun 28, 2022

    Myeloid Derived Suppressor Cells Control by Signal Regulatory

    Completed
    • Hepatocellular Carcinoma
    • Collection of human samples
    • (no location specified)
    Sep 10, 2021

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United Kingdom (Hu5F9-G4)

    Completed
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Cardiff, United Kingdom
    • +4 more
    Feb 19, 2019

    Advanced Cancer Trial in Guangzhou, Shanghai (TQB2928 injection)

    Recruiting
    • Advanced Cancer
    • TQB2928 injection
    • Guangzhou, Guangdong, China
    • +1 more
    Feb 15, 2022

    Erythrocytosis, Erythropoiesis Abnormal Trial in Copenhagen (Recombinant human erythropoietin)

    Completed
    • Erythrocytosis
    • Erythropoiesis Abnormal
    • Recombinant human erythropoietin
    • Copenhagen, Denmark
      Department of Nutrition, Exercise and Sports
    Apr 25, 2023